Cargando…

Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation

The fusion of 1,2,4-triazole and 1,3,4-thiadiazole rings results in a class of heterocycles compounds with an extensive range of pharmacological properties. A series of 1,2,4-triazolo[3,4-b]-1,2,4-thiadiazoles was synthesized and tested for its enzyme inhibition potential and anticancer activity. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trafalis, Dimitrios T., Sagredou, Sofia, Dalezis, Panayiotis, Voura, Maria, Fountoulaki, Stella, Nikoleousakos, Nikolaos, Almpanakis, Konstantinos, Deligiorgi, Maria V., Sarli, Vasiliki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066331/ https://www.ncbi.nlm.nih.gov/pubmed/33916378 http://dx.doi.org/10.3390/pharmaceutics13040493

Ejemplares similares

3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha
por: Sagredou, Sofia, et al.
Publicado: (2020)

Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden
por: Sagredou, Sofia, et al.
Publicado: (2021)

Azasteroid Alkylators as Dual Inhibitors of AKT and ERK Signaling for the Treatment of Ovarian Carcinoma
por: Dalezis, Panagiotis, et al.
Publicado: (2020)

Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay
por: Nikoleousakos, Nikolaos, et al.
Publicado: (2021)

8-Hydroxy-2’-Deoxyguanosine and 8-Nitroguanine Production and Detection in Blood Serum of Breast Cancer Patients in Response to Postoperative Complementary External Ionizing Irradiation of Normal Tissues
por: Verigos, Kosmas E., et al.
Publicado: (2020)

The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity
por: Baburajeev, C. P., et al.
Publicado: (2017)

How Far Are We from Prescribing Fasting as Anticancer Medicine?
por: Deligiorgi, Maria V., et al.
Publicado: (2020)

The Intriguing Thyroid Hormones–Lung Cancer Association as Exemplification of the Thyroid Hormones–Cancer Association: Three Decades of Evolving Research
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum
por: Deligiorgi, Maria V., et al.
Publicado: (2022)

A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Deligiorgi, Maria V., et al.
Publicado: (2023)

Synthesis and Biological Evaluation of a c(RGDyK) Peptide Conjugate of SRPIN803
por: Leonidis, George, et al.
Publicado: (2021)

Triazolo Based-Thiadiazole Derivatives. Synthesis, Biological Evaluation and Molecular Docking Studies
por: Kamoutsis, Charalampos, et al.
Publicado: (2021)

Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH(3)-Substituted Thiadiazole-Based Thioamide
por: Varna, Despoina, et al.
Publicado: (2023)

New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis
por: Barash, Uri, et al.
Publicado: (2021)

Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution
por: Deligiorgi, Maria V., et al.
Publicado: (2021)

Discovery of Fused Triazolo-thiadiazoles as Inhibitors of TNF-alpha: Pharmacophore Hybridization for Treatment of Neuropathic Pain
por: Sharma, Monika, et al.
Publicado: (2012)

Thiadiazole derivatives as anticancer agents
por: Szeliga, Monika
Publicado: (2020)

New 1,3,4-Thiadiazole Derivatives with Anticancer Activity
por: Janowska, Sara, et al.
Publicado: (2022)

Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors
por: Kurban, Berkant, et al.
Publicado: (2023)

In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
por: Geromichalou, Elena G., et al.
Publicado: (2022)

Chemical and Biological Characterization of the Anticancer Potency of Salvia fruticosa in a Model of Human Malignant Melanoma
por: Kyriakou, Sotiris, et al.
Publicado: (2021)

The novel IGF-IR/Akt–dependent anticancer activities of glucosamine
por: Song, Ki-Hoon, et al.
Publicado: (2014)

Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
por: Ye, Jianwen, et al.
Publicado: (2021)

Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
por: Baburajeev, C. P., et al.
Publicado: (2015)

Assessment of Methodological Pipelines for the Determination of Isothiocyanates Derived from Natural Sources
por: Kyriakou, Sotiris, et al.
Publicado: (2022)

Synthesis and Anticancer Activity of 1,3,4-Thiadiazoles with 3-Methoxyphenyl Substituent
por: Janowska, Sara, et al.
Publicado: (2022)

Synthesis and Biological Activity of 3-(2-Furanyl)-6-Aryl-1,2,4-Triazolo[3,4-b]-1,3,4 –Thiadiazoles
por: Zhang, Li-Xue, et al.
Publicado: (2002)

Synthesis and Antimicrobial Activity of Some New Thiadiazoles, Thioamides, 5-Arylazothiazoles and Pyrimido[4,5-d][1,2,4]triazolo[4,3-a]pyrimidines
por: Abdelhamid, Abdou O., et al.
Publicado: (2016)

3-Methyl-6-trichloromethyl-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole
por: Jia, Wei-min, et al.
Publicado: (2011)

An Evaluation of the Anti-Carcinogenic Response of Major Isothiocyanates in Non-Metastatic and Metastatic Melanoma Cells
por: Mitsiogianni, Melina, et al.
Publicado: (2021)

Synthesis and Preliminary Anticancer Activity Assessment of N-Glycosides of 2-Amino-1,3,4-thiadiazoles
por: Żurawska, Katarzyna, et al.
Publicado: (2021)

Akt inhibitors: mechanism of action and implications for anticancer therapeutics
por: Bhutani, Jaikrit, et al.
Publicado: (2013)

Biological activity of oxadiazole and thiadiazole derivatives
por: Atmaram, Upare Abhay, et al.
Publicado: (2022)

α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway
por: Jo, Hantae, et al.
Publicado: (2021)

Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5-c]quinazolines
por: Kovalenko, Sergiy I., et al.
Publicado: (2013)

A facile synthesis and anticancer activity of some novel thiazoles carrying 1,3,4-thiadiazole moiety
por: Gomha, Sobhi M., et al.
Publicado: (2017)

Synthesis and Anti-Proliferative Assessment of Triazolo-Thiadiazepine and Triazolo-Thiadiazine Scaffolds
por: Boraei, Ahmed T. A., et al.
Publicado: (2019)

Inhibitor Hijacking of Akt Activation
por: Okuzumi, Tatsuya, et al.
Publicado: (2009)

Synthesis and Pharmacological Activities of Some New Triazolo- and Tetrazolopyrimidine Derivatives
por: Bahashwan, Saleh A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_23711n8e8aas7j7fjmkuqfgl5o